“Clinical Lasting Response of Crizotinib in ALK Positive Lung Squamous Cell Carcinoma With Brain Metastasis”. European Journal of Oncology and Environmental Health 22, no. 2 (November 17, 2017): 95–97. Accessed April 29, 2024. https://www.mattioli1885journals.com/index.php/EJOEH/article/view/4800.